Variations in Managing Chronic Kidney Disease Associated With Type 2 Diabetes Across the United States and Validation of the FINE-CKD Model for Future Health Technology Assessments of Finerenone

---

Validation of the FINE-CKD Model for Future Health Technology Assessments for Finerenone in Patients With Chronic Kidney Disease And Type 2 Diabetes

Michał Pochopień, MSc;David Z. I. Cherney, MD, PhD;Aleksandra Drzewiecka, MSc;Kerstin Folkerts, MSc;Pierre Levy, PhD;Aurélie Millier, PhD;Stephen Morris, PhD;Monika Palarczyk, MSc;Prabir Roy-Chaudhury, MD, PhD;Sean D. Sullivan, PhD;Paul Mernagh, MCom

August 16th 2022

Article

---

Geographical Variation in Kidney Function Testing and Associations With Health Care Costs Among Patients With Chronic Kidney Disease and Type 2 Diabetes

Keith A. Betts, PhD;Jinlin Song, PhD;Jay Elliott, PhD;Neil Warnock, MD, MS, CHCQM;Ryan Farej, BS;Aozhou Wu, PhD;Rakesh Singh, PhD

August 16th 2022

Article

---

Participating Faculty: Variations in Managing Chronic Kidney Disease Associated With Type 2 Diabetes Across the United States and Validation of the FINE-CKD Model for Future Health Technology Assessments of Finerenone

August 16th 2022

Article